In Vitro Antibacterial Activity of Meropenem/RPX709, (a Carpabenem/ß-lactamase Inhibitor Combination) Against Contemporary Enterobacteriaceae Isolated from Intra-abdominal and Urinary Tract Infections in the United States
In Vitro Antibacterial Activity of Meropenem/RPX709, (a Carpabenem/ß-lactamase Inhibitor Combination) Against Contemporary Enterobacteriaceae Isolated from Intra-abdominal and Urinary Tract Infections in the United States, Lead author: Castanheira M, presented at ID Week, October 7-11, 2015, San Diego, CA
